Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Osiris Therapeutics (NASDAQ: OSIR ) are trading 11% higher today in what appears to be a delayed reaction to the company's Monday-night release of its first-quarter earnings.
So what: Osiris' first quarter resulted in $10.1 million in revenue -- 146% higher than the year-ago quarter and 25% higher than the fourth quarter -- and a loss of $0.02 per share. Both results topped Wall Street's expectations, which had been for $9 million in revenue and a loss of $0.08 per share. The company is now fully engaged in commercializing and marketing Grafix, a wound-repair membrane, and as a result its administrative and sales expenses grew to $7.2 million, from $2.4 million a year ago.
Now what: Osiris is certainly making progress back toward profitability, which it left behind (on an adjusted basis) in 2012, but it may take time for its new marketing push to pay off on the bottom line. But the company's shares have yet to reclaim the levels they shot to after Osiris' strong Phase 3 test results last year, which could mean that investors who have taken money off the table could be missing out on what is, by Fool health-care specialist Keith Speights' calculations, a $2-billion-plus market opportunity. Grafix is only covered by Medicare in nine states so far, which means that there could be quite a bit more upside to Grafix's revenue as Osiris obtains coverage in more states.
Will this stock be your next multi-bagger?
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.